Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Solanum nigrum may help treat hair loss.

Women also use 5α-reductase inhibitors, and their effects differ from men.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Finasteride does not negatively affect male reproductive function.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

5-alpha reductase inhibitors do not increase hip fracture risk.

β-sitosterol and brassicasterol may help treat hair loss.

GI197111X is best dissolved in Capmul MCM for trials.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

New compounds show promise as nonsteroidal treatments for hair loss.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Some dibenzo compounds might help treat cancer with fewer side effects.